Image

Asia-Pacific (APAC) Biomarkers Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Dec 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Dec 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific (APAC) Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy),  Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)-Industry Trends and Forecast to 2029

 Asia-Pacific (APAC) Biomarkers Market Market Analysis and Insights of Biomarkers  Market

The biomarkers market is expected to witness market growth at a rate of 16.7% in the forecast period of 2022 to 2029. Data Bridge Market Research report on biomarkers market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the rising population is escalating the growth of biomarkers market.

Biomarkers (also referred as signature molecule or molecular marker) are basically utilized to check that how body responds to a treatment of any condition or disease and assist in examining the organ functions and other health conditions. These play a vital role in the imaging technology so that they can provide clear imaging of oncology tumors and other problems.

Major factors that are expected to boost the growth of the biomarkers market in the forecast period are the increasing number of patients with increasing demand for non-invasive cancer diagnostic. Furthermore, the increasing cases of cancer patient and researching programming, rising unhealthy lifestyle and increasing chronic diseases like diabetes, cardiovascular disorders is further anticipated to propel the growth of the biomarkers market. On the other hand, the high cost of treatment and high capital expenditure on devices is further projected to impede the growth of the biomarkers market in the timeline period.

In addition, the focus on early detection of medical problems in minimally invasive manner along with increasing government and research institute initiatives for research and development projects will further provide potential opportunities for the growth of the biomarkers market in the coming years. However, several unfavorable policies and technical issues related to sample collection and storage, and proving the clinical validity in biomarker-based tests might further challenge the growth of the biomarkers market in the near future.

This biomarkers market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research biomarkers market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific (APAC) Biomarkers Market Scope and Market Size

The biomarkers market is segmented on the basis of type, product, mechanism, application, and diseases indication. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, market is segmented into safety biomarkers, efficacy biomarkers and validation biomarkers. The efficacy biomarkers was sub-segmented into surrogate biomarkers, predictive biomarkers, prognostic biomarkers and pharmacodynamic biomarkers.
  • On the basis of product, biomarkers market is segmented into consumables, services, software and growth hormone therapy.
  • On the basis of mechanism, biomarkers market is segmented into genetic, epigenetic, proteomic, lipidomic, and other mechanisms.
  • On the basis of application, biomarkers market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other.
  • Based on disease indication, biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders and others.

Biomarkers Market Country Level Analysis

The biomarkers market is analyzed and market size insights and trends are provided by type, product, mechanism, application, and diseases indication as referenced above.

The countries covered in the biomarkers market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China dominates the biomarkers market due to the rise in the CVD disease and the geriatric population.

The country section of the biomarkers market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The biomarkers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for biomarkers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomarkers market. The data is available for historic period 2010-2020.

Competitive Landscape and Biomarkers Market Share Analysis

The biomarkers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biomarkers market.

Some of the major players operating in the biomarkers market report are Enzo Biochem Inc., Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer Inc., QIAGEN, Agilent Technologies, Inc., Bruker, Epigenomics AG, MESO SCALE DIAGNOSTICS, LLC, EKF Diagnostics Holdings plc, General Electric Company, Nexus-Dx, LifeSign LLC, F. Hoffmann-La Roche Ltd., among others.


SKU-

Why Choose Us


Frequently Asked Questions